Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
BioTelemetry, Inc. (NASDAQ: BEAT) shares jumped 13.60 percent to close at $11.19 a share Thursday. The stock traded between $10.82 and $11.67 on 2.0 million shares traded. The company reported an adjusted net income of $1.4 million, or $0.05 per share, for the fourth quarter of 2013, compared to an adjusted net loss of $2.3 million, or $(0.09) a share, a year ago. Shares of BioTelemetry are up approximately 40.0 percent year-to-date.
Get more information on BioTelemetry free access to the in-depth equity report at:
www.FiveStarEquities.com/BEAT
Cell Therapeutics Inc. (NASDAQ: CTIC) shares spiked 13.11 percent to close at $3.97 a share Thursday. The stock traded between $3.73 and $4.00 on volume 8.38 million shares traded. The company announced that the National Institute for Health and Care Excellence published final guidance recommending prescription of PIXUVRI. Shares of Cell Therapeutics are up approximately 105.0 percent year-to-date.
Get more information on Cell Therapeutics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CTIC
GrafTech International Ltd. (NYSE: GTI) shares increased 9.07 percent to close at $10.34 a share Thursday. The stock traded between $9.55 and $10.88 on volume of 5.89 million shares traded. The company’s expected revenue growth of between 15 percent and 20 percent for fiscal 2014 topped analysts’ expectations. Shares of GrafTech International are down approximately 8.0 percent year-to-date.
Get more information on GrafTech International and free access to the in-depth equity report at:
www.FiveStarEquities.com/GTI
MedAssets, Inc. (NASDAQ: MDAS) shares surged 13.55 percent to close at $25.06 a share Thursday. The stock traded between $23.50 and $25.74 on volume of 2.86 million shares traded. The company reported a net income of $7.8 million for the fourth quarter of 2013, compared to a net loss of $14.4 million a year ago. Shares of MedAssets are up approximately 26.0 percent year-to-date.
Get more information on MedAssets and free access to the in-depth equity report at:
www.FiveStarEquities.com/MDAS
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]